Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Osimertinib/Savolitinib Combo Shows Promise in NSCLC
SAN DIEGO — Combination therapy with osimertinib and savolitinib could become a novel first-line treatment option for patients with de novo MET-aberrant, EGFR-mutated advanced non–small cell lung cancer (NSCLC), according to results of the phase 2 FLOWERS study. Compared with…
English